Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

[Trending] Learning Disability Treatment Market Size Will Attain USD 31.60 Billion by 2030 Growing at 6.26% CAGR – Exclusive Report by Zion Market Research | Global Learning Disability Treatment Market Size, Share, Trends Analysis Report

Published

on

<!– Name:DistributionId Value:8835189 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2791 –> <!– Name:CustomerId Value:1092386 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:233d8a2c-4262-4636-9602-8dcf317b41d1 –>

NEW YORK, United States, May 09, 2023 (GLOBE NEWSWIRE) — Zion Market Research has published a new research report titled “Learning Disability Treatment Market By Therapy (Stimulant Medication, Non-Stimulant Medication, Occupational Therapy, Complimentary Therapy, Others) By Indication (Dyslexia, Dyspraxia, Attention Deficit Hyperactivity Disorder (ADHD), Others) By End-User (Hospitals, Clinic, Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.

“According to the latest research study, the demand of global Learning Disability Treatment Market size & share in terms of revenue was valued at USD 21.94 billion in 2022 and it is expected to surpass around USD 31.60 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 6.26% during the forecast period 2023 to 2030.”

What is Learning Disability Treatment? How big is the Learning Disability Treatment Industry?

Report Overview:

Learning disabilities refer to a group of disorders that affect a person’s ability to process information effectively. Treatment for learning disabilities typically involves a combination of educational interventions, behavioral therapy, and medication management. Educational interventions may include special education programs, individualized learning plans, and accommodations such as extended time on tests or assistive technology. Behavioral therapy may involve social skills training, cognitive-behavioral therapy, or parent training.

Medication management may be used to treat specific symptoms such as attention deficit hyperactivity disorder (ADHD) or depression. With the development of innovative therapies and drugs, the outlook for individuals with learning disabilities has improved significantly in recent years. However, challenges such as lack of awareness, high treatment costs, and stigma associated with learning disabilities remain significant barriers to optimal treatment outcomes.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs – https://www.zionmarketresearch.com/sample/learning-disability-treatment-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
  • About 214+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
  • Zion Market Research Methodology


Global Learning Disability Treatment Market Dynamics:

The global learning disability treatment market is driven by several factors, including the increasing prevalence of learning disabilities worldwide, rising awareness & diagnosis rates, availability of advanced treatment options, and supportive government initiatives. Rising investment in research & development activities, technological advancements in medical devices & drugs, and the development of innovative therapies for the treatment of learning disabilities further drive the growth of the market during the forecast period.

However, the learning disability treatment industry also faces restraints such as the high cost of treatment, lack of awareness in developing economies, and inadequate reimbursement policies. The stigma associated with learning disabilities, the complexity of the disorders, and the lack of standardization in diagnosis & treatment practices are other challenges. Nevertheless, increasing focus on precision medicine, personalized treatment options, and the use of advanced technologies such as artificial intelligence and virtual reality for the development of innovative therapies create ample opportunities for the growth of the market during the forecast period.

Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/learning-disability-treatment-market

Report Scope

Report Attribute Details
Market Size in 2022 USD 21.94 Billion
Projected Market Size in 2030 USD 31.60 Billion
CAGR Growth Rate 6.26% CAGR
Base Year 2022
Forecast Years 2023-2030
Key Market Players Johnson & Johnson, Pfizer, Inc., Novartis AG, GlaxoSmithKline plc, Shire, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Allergan, Inc., Bausch Health Companies Inc., Merck & Co., Inc., Biogen Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Takeda Pharmaceutical Co. Ltd., Sanofi S.A., Bayer AG, Mylan N.V., Astellas Pharma Inc., Otsuka Holdings Co., Ltd., and AstraZeneca.
Key Segment By Therapy, By Indication, By End-User, And By Region
Major Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Purchase Options Request customized purchase options to meet your research needs. Explore purchase options

Learning Disability Treatment Market: Segmentation Analysis

The global learning disability treatment market is segmented based on therapy, indication, end-user, and region.

Based on therapy, the market is bifurcated into Stimulant Medication, Non-Stimulant Medication, Occupational Therapy, Complimentary Therapy, and others. The stimulant medication segment held the largest market share in 2022 and is further predicted to grow rapidly at a significant CAGR during the forecast period. This is mainly due to the increasing prevalence of attention-deficit/hyperactivity disorder (ADHD), the effectiveness of stimulant medications in treating ADHD symptoms, and the growing awareness & acceptance of ADHD as a legitimate medical condition that requires treatment. Additionally, the ease of access to stimulant medications and the relatively low cost compared to other treatment options may also be contributing factors to the growth of this segment.

Based on indication, the learning disability treatment industry is segmented into Dyslexia, Dyspraxia, Attention Deficit Hyperactivity Disorder (ADHD), and others. The dyslexia segment held the largest market share in 2022 and is further predicted to grow at an exponential CAGR during the forecast period. One of the main drivers is the increasing recognition and diagnosis of dyslexia, which has led to a growing demand for effective treatments.

Additionally, advances in neuroscience and educational research have led to the development of new and improved interventions for dyslexia, including evidence-based reading programs, multisensory teaching methods, and assistive technologies. Furthermore, changes in legislation and educational policies in some countries have mandated greater support for students with dyslexia, leading to increased investment in educational interventions and accommodations. Moreover, growing awareness and understanding of the impact of dyslexia on individuals and society as a whole, have led to greater advocacy and support from organizations, governments, and other stakeholders, driving innovation and investment in the dyslexia segment.

Based on end-user, the market is segmented into hospitals and clinics segment. The clinic segment is predicted to grow rapidly at a significant CAGR during the forecast period.

The global Learning Disability Treatment market is segmented as follows:

By Therapy

  • Stimulant Medication
  • Non-Stimulant Medication
  • Occupational Therapy
  • Complimentary Therapy
  • Others

By Indication

  • Dyslexia
  • Dyspraxia
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Others

By End-User

  • Hospitals
  • Clinic
  • Others

Browse the full “Learning Disability Treatment Market By Therapy (Stimulant Medication, Non-Stimulant Medication, Occupational Therapy, Complimentary Therapy, Others) By Indication (Dyslexia, Dyspraxia, Attention Deficit Hyperactivity Disorder (ADHD), Others) By End-User (Hospitals, Clinic, Others), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030.” Report at https://www.zionmarketresearch.com/report/learning-disability-treatment-market

Competitive Landscape

Some of the main competitors dominating the global Learning Disability Treatment market include – 

  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • GlaxoSmithKline plc
  • Shire
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Allergan Inc.
  • Bausch Health Companies Inc.
  • Merck & Co. Inc.
  • Biogen Inc.
  • F. Hoffmann-La Roche AG
  • AbbVie Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Sanofi S.A.
  • Bayer AG
  • Mylan N.V.
  • Astellas Pharma Inc.
  • Otsuka Holdings Co. Ltd.
  • AstraZeneca.

 Key Insights from Primary Research:

  • According to the analysis shared by our research analyst, the Learning Disability Treatment market is likely to expand at a CAGR of around 6.26% during the forecast period (2023-2030).        
  • In terms of revenue, the Learning Disability Treatment market size was valued at around US$ 21.94 billion in 2022 and is projected to reach US$ 31.60 billion by 2030.
  • The learning disability treatment market is driven by various factors, including the increasing prevalence of learning disabilities worldwide.
  • Based on therapy, the stimulant medication held the largest market share in 2022.
  • Based on indication, the dyslexia segment held the dominating market share in 2022.
  • Based on region, the North American region held the largest market share in 2022.

Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/learning-disability-treatment-market

Key questions answered in this report:

  • What is the market size and growth rate forecast for Learning Disability Treatment industry?
  • What are the main driving factors propelling the Learning Disability Treatment Market forward?
  • What are the leading companies in the Learning Disability Treatment Industry?
  • What segments does the Learning Disability Treatment Market cover?
  • How can I receive a free copy of the Learning Disability Treatment Market sample report and company profiles?

Key Offerings:

  • Market Size & Forecast by Revenue | 2023−2030
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
  • Market Segmentation – A detailed analysis By Therapy, By Indication, By End-User, And By Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements – https://www.zionmarketresearch.com/custom/5823

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

The North American region held the` largest learning disability treatment market share in 2022 and is further predicted to grow at a remarkable CAGR during the forecast period. One of the main drivers is the increasing prevalence of learning disabilities in the region, which has led to a growing demand for effective treatments. Additionally, advances in medical research and technology have led to the development of new and innovative therapies and medications for learning disabilities.

Moreover, changes in education policies and legislation have mandated greater support and accommodations for students with learning disabilities, driving investment in educational interventions and specialized services. In addition, the increasing adoption of telemedicine and digital health technologies has improved access to learning disability treatments and services, particularly in rural and underserved areas.

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Recent Developments

  • In 2020, the pharmaceutical company, Takeda, received approval from the FDA for a new ADHD medication called Trintellix. Trintellix is a selective serotonin reuptake inhibitor (SSRI) that has shown promise in reducing symptoms of ADHD in clinical trials. This approval represents a significant development in the ADHD treatment market, providing patients with a new option for managing their symptoms.
  • In 2019, the educational technology company, Amplify, launched a new reading program called mCLASS® with DIBELS® 8th Edition. This program uses technology to provide real-time feedback and assessments to help students improve their reading skills. This development represents a significant advancement in the use of technology to support learning disabilities and has the potential to improve outcomes for students with dyslexia and other reading disabilities.

To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/learning-disability-treatment-market

Browse Other Related Research Reports from Zion Market Research:

About Zion Market Research:

Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/

Follow Us on Twitter: https://twitter.com/zion_research

Follow Us on Facebook: https://www.facebook.com/zionmarketresearch

Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/

Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Japan: +81 50 5806 9039

India: +91 7768 006 007

Web: https://www.zionmarketresearch.com/

Blog: https://zmrblog.com/

Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?

Email Directly Here with Detail Information: [email protected]

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

SUPCON Unveils Groundbreaking Products in June, Including the World’s First UCS

Published

on

supcon-unveils-groundbreaking-products-in-june,-including-the-world’s-first-ucs

HANGZHOU, China, April 24, 2024 /PRNewswire/ — In June, SUPCON (688777) is poised to launch two groundbreaking products in Singapore: the world’s first UCS (Universal Control System) and TPT (Time-Series Pre-trained Transformer), the first time-series model in the process industry.

UCS, a revolutionary innovation from SUPCON, is set to revolutionize the 50-year-old DCS architecture, promising to eliminate traditional control cabinets.
TPT, as the pioneering time-series model in the process industry, will replace numerous traditional industrial apps and overcome unsolved industrial challenges.
SUPCON, founded in 1999, is a prominent global provider of intelligent manufacturing solutions for process industries. The company is committed to the development and application of AI technology through the integration of advanced products and extensive industry know-how. With a global customer exceeding 30,000, SUPCON’s products address all needs across over 50 countries and regions, encompassing sectors like oil & gas, refinery & petrochemical, chemical, etc. Aiming at high-quality and sustainable development, SUPCON is on the way to facilitate the automation and intelligentization of the global process industry.
In 2023, SUPCON’s core products, the Distributed Control System (DCS) and the Safety Instrumented System (SIS), both claimed the top market share position in China, achieving respective figures of 37.8% and 33.7%. Notably, the DCS has maintained the No.1 position for a consecutive 13th year.

View original content:https://www.prnewswire.co.uk/news-releases/supcon-unveils-groundbreaking-products-in-june-including-the-worlds-first-ucs-302125406.html

Continue Reading

Artificial Intelligence

Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation

Published

on

automation-anywhere-appoints-tim-mcdonough-as-chief-marketing-officer-to-drive-global-awareness-and-growth-for-the-leader-in-ai-powered-automation

SAN JOSE, Calif., April 23, 2024 /PRNewswire/ — Automation Anywhere, a leader in AI-powered automation solutions, announced that AI marketing leader ﷟Tim McDonough joined the company as chief marketing officer (CMO). McDonough, who brings more than two decades of experience in driving growth across startups and Fortune 100 companies, will shape and lead Automation Anywhere’s global brand and growth strategies and go-to-market functions.

 
McDonough joins Automation Anywhere from Intel, where he recently served as vice president and CMO of AI and data centers. McDonough oversaw the transformation of the $14 billion-plus business unit, while guiding the company’s strategy and positioning in the AI market.
“Tim joins us at an incredible time in our journey as we experience a new phase of growth ignited by the transformative benefits of our generative AI process automation models that are transforming our customers’ businesses,” said Mihir Shukla, CEO, Automation Anywhere. “Tim’s impressive experience will be instrumental in our efforts to empower organizations to achieve amazing results by automating more than forty percent of workflows and tasks, and saving millions, even billions, of dollars.”
Prior to Intel, McDonough held executive roles at leading technology companies, including Unity Technologies, Qualcomm, and Microsoft. McDonough’s track record of enterprise and C-suite marketing spans developed and emerging technologies, including AI tools, applications, software-as-a-service (SaaS) solutions, and developer ecosystems.
“I’m looking forward to helping lead Automation Anywhere through its next phase growth as it helps companies transform their business,” said McDonough. “Seeing how customers are innovating with Automation Anywhere’s platform demonstrated to me the incredible market opportunity we have. When you combine automation with generative AI, customers can now go beyond task or departmental impact and automate at an enterprise level, empowering companies and employees to do their very best work.”
McDonough’s appointment comes at a time of remarkable opportunity for the company, marked by Automation Anywhere’s recent record-breaking fourth-quarter performance, continued profitability, and strong outlook in its current fiscal year. Last quarter, Automation Anywhere reported 50 percent growth in large enterprise deals from the previous quarter, highlighting the company’s momentum and strong market position.  
About Automation Anywhere  
Automation Anywhere is the leader in AI-powered process automation that puts AI to work across organizations. The company’s Automation Success Platform is powered with generative AI and offers process discovery, RPA, end-to-end process orchestration, document processing, and analytics, with a security and governance-first approach. Automation Anywhere empowers organizations worldwide to unleash productivity gains, drive innovation, improve customer service, and accelerate business growth. The company is guided by its vision to fuel the future of work by unleashing human potential through AI automation. Learn more at http://www.automationanywhere.com/.  
Engage with Automation Anywhere  
WebinarsLinkedInThreadsFacebookInstagramPhoto – https://mma.prnewswire.com/media/2395055/Tim_Headshot.jpgLogo – https://mma.prnewswire.com/media/2383572/4665982/Automation_Anywhere_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/automation-anywhere-appoints-tim-mcdonough-as-chief-marketing-officer-to-drive-global-awareness-and-growth-for-the-leader-in-ai-powered-automation-302125158.html

Continue Reading

Artificial Intelligence

AI Supercomputing Market Growing at +21% CAGR as Industries Evolve Data Analysis

Published

on

ai-supercomputing-market-growing-at-+21%-cagr-as-industries-evolve-data-analysis

USA News Group News Commentary
VANCOUVER, BC, April 23, 2024 /PRNewswire/ — USA News Group News Commentary – Numerous industries are making the shift towards using Artificial Intelligence (AI) supercomputers in leveraging powerful computing systems to address complex challenges, and analyze massive datasets. According to analysts at Markets and Markets the AI supercomputer market is projected to grow at a CAGR of 22% through 2028 to a value of US$3.3 billion. This high level of growth is echoed by analysts at Technavio, who are projecting nearly 21% growth through 2027, however, they are seeing the overall supercomputer market much higher, growing by US$17.6 billion along the way. Several international groups are with massive investments in the billions to evolve their operations to include AI supercomputing, including in Denmark, the UK, Japan, the UAE and the USA. Powering this shift behind the scenes are several tech developers, who this week have been updating the market with their current developments, including: Avant Technologies Inc. (OTC: AVAI), NVIDIA Corporation (NASDAQ: NVDA) (NEO: NVDA), Microsoft Corporation (NASDAQ: MSFT) (NEO: MSFT), D-Wave Quantum Inc. (NYSE: QBTS), and Rigetti Computing, Inc. (NASDAQ: RGTI, RGITW).

The article continued: Moving forward, new regulations and safeguards are being put into place, as seen in the USA when the Biden Administration enacted an AI Executive Order to create new standards for AI safety and security. As well, the Council of the European Union filed a proposal for the regulation of harmonized rules on AI in the EU.
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions
Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence technology (AI) company specializing in the development of advanced AI and data center infrastructure solutions, announced today that it’s introducing a state-of-the-art supercomputing network and comprehensive licensable dataset. Avant will be collaborating with its technology partner, Wired4Tech, to launch these pivotal developments, which are engineered to accelerate AI adoption and innovation across a broad spectrum of industries.
“Avant’s supercomputing network and our expansive licensable dataset will facilitate significant advancements in AI- driven solutions,” said Danny Rittman, Chief Information Officer of Avant of the launch. “By providing robust computational resources and a rich dataset, Avant is set to eliminate many of the technical and financial barriers that have traditionally hampered AI development. This initiative aims to empower developers with the tools necessary to create more sophisticated and efficient AI models, driving progress and innovation in innumerable fields.”
Highlights of Avant’s Offerings:
Versatile AI Dataset: Available from Q3, this dataset will be regularly updated to support a wide array of AI projects, providing a solid foundation for development, and reducing the time to market for AI solutions.Dynamic Resource Scaling: The network dynamically adjusts computing resources to meet real-time demands, maximizing efficiency and minimizing costs.Accelerated AI Processing: Utilizes cutting-edge distributed computing to dramatically reduce data processing times, enabling rapid iteration and deployment of AI models.Robust Security Measures: Top-tier security protocols are in place to ensure data integrity and compliance with stringent regulatory standards.Seamless Integration: Designed to integrate smoothly with existing AI development environments, minimizing disruptions and simplifying technology adoption.Avant is committed to advancing the AI landscape by providing scalable solutions that will benefit diverse sectors looking to harness the power of artificial intelligence.
CONTINUED… Read this and more news for Avant Technologies at: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/
In other industry developments and happenings in the market this week include:
NVIDIA Corporation (NASDAQ: NVDA) (NEO: NVDA), a global leader in providing graphics and compute and networking solutions, recently received an investment of ~US$960 million from Japanese telecommunications company Softbank to enhance its supercomputing power and to support an ambitious generative AI (GenAI) strategy.
Generative AI is increasingly being incorporated into products and services across multiple sectors. A recent projection by Statista, a research firm based in Germany, predicts that the market for generative AI in Japan will expand to approximately $13 billion by 2030, representing a 17x increase from its size in 2023.
Microsoft Corporation (NASDAQ: MSFT) (NEO: MSFT), a global leader in developing and supporting software, services, devises and solutions recently announced it would be investing $1.5 billion into Abu Dhabi’s G42, the leading UAE-based AI tech holding company, to accelerate AI development and global expansion.
“Microsoft’s investment in G42 marks a pivotal moment in our company’s journey of growth and innovation, signifying a strategic alignment of vision and execution between the two organizations,” said H.H. Sheikh Tahnoon bin Zayed Al Nahyan, Chairman of G42. “This partnership is a testament to the shared values and aspirations for progress, fostering greater cooperation and synergy globally.”
G42 will operate its AI applications and services on Microsoft Azure, collaborating to offer advanced AI solutions to global public sector clients and large enterprises. Together, G42 and Microsoft aim to enhance AI and digital infrastructure across the Middle East, Central Asia, and Africa. This collaboration will help these regions gain fair access to services that address key government and business issues, while upholding the highest standards of security and privacy.
D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers recently announced the launch the first fast-anneal feature, available now on all of D-Wave’s quantum processing units (QPUs) in the LeapTM real-time quantum cloud service. The fast-anneal feature has been central to D-Wave’s key research achievements, as highlighted in publications in Nature Physics and Nature, showing how annealing quantum computing outperforms traditional algorithms in tackling complex optimization problems.
“Providing direct access to Fast Anneal, which has been at the heart of D-Wave’s recent advancements, represents a significant step forward in our mission to provide customers with the resources they need to drive innovation and achieve extraordinary results,” said Dr. Alan Baratz, CEO of D-Wave. “We believe it will further empower them to build industry-shaping applications with the most powerful quantum computing environment available today.”
With enhanced control allowing for notably quicker annealing times than before, this feature enables customers to replicate and expand upon D-Wave’s significant optimization results. Now widely available, this feature allows users to execute quantum computations at unprecedented speeds, significantly mitigating issues like thermal fluctuations and noise that typically disrupt quantum calculations.
Rigetti Computing, Inc. (NASDAQ: RGTI, RGITW), a pioneer in full-stack quantum-classical computing, recently announced the successful completion of its Innovate UK project with Oxford Instruments to launch one of the first UK-based quantum computers. The consortium also included the Quantum Software Lab at the University of Edinburgh, Phasecraft, and Standard Chartered Bank, with financial backing from the UK government’s Quantum Technologies Challenge, led by UK Research & Innovation (UKRI).
 “Completing this project, with the end result being a useful 32-qubit quantum computer, is an exceptional achievement for all of the project partners,” said Dr. Subodh Kulkarni, CEO of Rigetti. “It takes a world-class team to build and deploy a quantum computer. The UK has become a world leader in quantum computing technologies, and we are excited to continue to contribute to its quantum computing capabilities. Additionally, Rigetti plans to leverage this experience to continue to develop our UK quantum computing leadership as we embark on deploying a 24-qubit Ankaa-class quantum computer at the NQCC’s Harwell campus.”
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/ 
CONTACT:USA NEWS [email protected] (604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/ai-supercomputing-market-growing-at-21-cagr-as-industries-evolve-data-analysis-302124990.html

Continue Reading

Trending